153 related articles for article (PubMed ID: 18190239)
21. A comparative study on the protective effects of 17beta-estradiol, biochanin A and bisphenol A on mammary gland differentiation and tumorigenesis in rats.
Yin H; Ito A; Bhattacharjee D; Hoshi M
Indian J Exp Biol; 2006 Jul; 44(7):540-6. PubMed ID: 16872042
[TBL] [Abstract][Full Text] [Related]
22. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
[TBL] [Abstract][Full Text] [Related]
23. Effects of the aromatase inhibitor letrozole on in utero development in rats.
Tiboni GM; Marotta F; Rossi C; Giampietro F
Hum Reprod; 2008 Aug; 23(8):1719-23. PubMed ID: 18487213
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
Gottardis MM; Bischoff ED; Shirley MA; Wagoner MA; Lamph WW; Heyman RA
Cancer Res; 1996 Dec; 56(24):5566-70. PubMed ID: 8971154
[TBL] [Abstract][Full Text] [Related]
25. Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.
Christov K; Grubbs CJ; Shilkaitis A; Juliana MM; Lubet RA
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5488-96. PubMed ID: 17875779
[TBL] [Abstract][Full Text] [Related]
26. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
27. Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.
Kumru S; Yildiz AA; Yilmaz B; Sandal S; Gurates B
Gynecol Endocrinol; 2007 Oct; 23(10):556-61. PubMed ID: 17952760
[TBL] [Abstract][Full Text] [Related]
28. N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats.
Tsukamoto R; Mikami T; Miki K; Uehara N; Yuri T; Matsuoka Y; Okazaki K; Tsubura A
Oncol Rep; 2007 Aug; 18(2):337-42. PubMed ID: 17611653
[TBL] [Abstract][Full Text] [Related]
29. Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumor growth in rats.
Suh N; Paul S; Lee HJ; Ji Y; Lee MJ; Yang CS; Reddy BS; Newmark HL
Nutr Cancer; 2007; 59(1):76-81. PubMed ID: 17927505
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PhIP-induced mammary carcinogenesis in female rats by ingestion of freeze-dried beer.
Nozawa H; Nakao W; Takata J; Arimoto-Kobayashi S; Kondo K
Cancer Lett; 2006 Apr; 235(1):121-9. PubMed ID: 15946793
[TBL] [Abstract][Full Text] [Related]
31. Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxyvitamin D5.
Mehta RG
Eur J Cancer; 2004 Oct; 40(15):2331-7. PubMed ID: 15454260
[TBL] [Abstract][Full Text] [Related]
32. Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats.
Lubet RA; Steele VE; Casebolt TL; Eto I; Kelloff GJ; Grubbs CJ
Carcinogenesis; 1994 Dec; 15(12):2775-80. PubMed ID: 8001234
[TBL] [Abstract][Full Text] [Related]
33. A novel tocolytic agent: effects of letrozole on gestational length and parturition time.
Kafali H; Iriadam M
Am J Perinatol; 2007 May; 24(5):323-6. PubMed ID: 17516308
[TBL] [Abstract][Full Text] [Related]
34. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats.
Manna S; Chakraborty T; Ghosh B; Chatterjee M; Panda A; Srivastava S; Rana A; Chatterjee M
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):5-14. PubMed ID: 18614344
[TBL] [Abstract][Full Text] [Related]
35. Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis.
Orendas P; Kubatka P; Kajo K; Stollarova N; Kassayova M; Bojkova B; Pec M; Nosal V; Kiskova T; Zihlavnikova K; Karsnakova R
Neoplasma; 2012; 59(4):469-74. PubMed ID: 22489703
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA).
Cohen LA; Amin S; Marks PA; Rifkind RA; Desai D; Richon VM
Anticancer Res; 1999; 19(6B):4999-5005. PubMed ID: 10697502
[TBL] [Abstract][Full Text] [Related]
37. Effect of prolonged psychoemotional stress and melatonin on experimental mammary carcinogenesis in female rats.
Kassayová M; Friedmanová L; Orendás P; Kubatka P; Bojková B; Bobrov N; Ahlersová E; Ahlers I
Neoplasma; 2007; 54(3):251-5. PubMed ID: 17447859
[TBL] [Abstract][Full Text] [Related]
38. Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice.
Luthra R; Kirma N; Jones J; Tekmal RR
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):461-7. PubMed ID: 14623545
[TBL] [Abstract][Full Text] [Related]
39. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.
Anzano MA; Byers SW; Smith JM; Peer CW; Mullen LT; Brown CC; Roberts AB; Sporn MB
Cancer Res; 1994 Sep; 54(17):4614-7. PubMed ID: 8062253
[TBL] [Abstract][Full Text] [Related]
40. The combination of genistin and ipriflavone prevents mammary tumorigenesis and modulates lipid profile.
Hooshmand S; Khalil DA; Murillo G; Singletary K; Kamath SK; Arjmandi BH
Clin Nutr; 2008 Aug; 27(4):643-8. PubMed ID: 18571816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
